
Claris Lifesciences revives talks to sell injectables business
Sources suggest that it has evinced interest amongst pharma companies like Cadila Healthcare, Dr Reddy’s Labs, Torrent Pharma amongst others.
Sources suggest that it has evinced interest amongst pharma companies like Cadila Healthcare, Dr Reddy’s Labs, Torrent Pharma amongst others.
KKR may hold about 5% stake in Dalmia Bharat as part of the equity-cum-cash deal. The deal is expected to value Dalmia’s subsidiary at around Rs 8,500 crore.
Negotiations on valuations are currently on between the parties and the deal is expected to be closed by March 31, 2016, a source said.
India's largest car maker Maruti is all set to win the minority votes in favour of its plans to let parent, Suzuki, build the Gujarat plant.
Sources with direct knowledge suggest that debt-laden Alok Industries will be brought under Strategic Debt Restructuring by the lenders.
CPPIB is expected to commit $500 million to the fund which will provide short-term financial support to debt-laden companies, sources confirmed.
Vijay Mallya has vowed to settle his dues with regard to Kingfisher Airlines by this fiscal end and the deal will give him cash to settle a large part of Rs 6200 cr debt.
Gammon India entered the CDR package by lenders in September 2013 and has made several efforts to sell assets to pare down its massive debt pile of Rs 13,000 crore.
Property deals are back, in a major realty transaction in upmarket Mumbai, Crompton Greaves has sold its iconic corporate office in Worli.
Crompton Greaves Global's debt stands at Rs 1800 crore as of FY15, out of the Rs 2600 crore total debt on CG’s books.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service